DE3777721D1 - Zusammensetzungen zur parenteralen verabreichung und deren verwendung. - Google Patents

Zusammensetzungen zur parenteralen verabreichung und deren verwendung.

Info

Publication number
DE3777721D1
DE3777721D1 DE8787111217T DE3777721T DE3777721D1 DE 3777721 D1 DE3777721 D1 DE 3777721D1 DE 8787111217 T DE8787111217 T DE 8787111217T DE 3777721 T DE3777721 T DE 3777721T DE 3777721 D1 DE3777721 D1 DE 3777721D1
Authority
DE
Germany
Prior art keywords
compositions
parenteral administration
parenteral
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787111217T
Other languages
English (en)
Inventor
William Steber
Richard Fishbein
Susan Mancini Cady
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DE3777721D1 publication Critical patent/DE3777721D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE8787111217T 1986-08-11 1987-08-04 Zusammensetzungen zur parenteralen verabreichung und deren verwendung. Expired - Fee Related DE3777721D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89560886A 1986-08-11 1986-08-11

Publications (1)

Publication Number Publication Date
DE3777721D1 true DE3777721D1 (de) 1992-04-30

Family

ID=25404759

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787111217T Expired - Fee Related DE3777721D1 (de) 1986-08-11 1987-08-04 Zusammensetzungen zur parenteralen verabreichung und deren verwendung.

Country Status (16)

Country Link
EP (1) EP0257368B1 (de)
JP (1) JP2571790B2 (de)
AR (1) AR243079A1 (de)
AT (1) ATE74009T1 (de)
AU (1) AU597708B2 (de)
CA (1) CA1296627C (de)
DE (1) DE3777721D1 (de)
DK (1) DK169123B1 (de)
ES (1) ES2039219T3 (de)
FI (1) FI873465A (de)
GR (1) GR3004138T3 (de)
HU (1) HU203662B (de)
IE (1) IE65146B1 (de)
IL (1) IL83462A (de)
NZ (1) NZ221391A (de)
ZA (1) ZA875898B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857505A (en) * 1987-03-09 1989-08-15 American Cyanamid Company Sustained release compositions for parenteral administration and their use
GB8725427D0 (en) * 1987-10-30 1987-12-02 Lilly Industries Ltd Somatotropin formulations
CA1332918C (en) * 1988-07-26 1994-11-08 Colin G. Scanes Devices and methods for growth promotion in poultry roasters
US5106631A (en) * 1989-07-17 1992-04-21 American Cyanamid Company Cheese production
US5188895A (en) * 1989-08-31 1993-02-23 Mitsui Petrochemical Industries, Ltd. Split fibers, integrated split fiber articles and method for preparing the same
AU6430190A (en) * 1989-10-10 1991-05-16 Pitman-Moore, Inc. Sustained release composition for macromolecular proteins
FR2663223B1 (fr) * 1990-06-14 1994-12-02 Af Aplicaciones Far Lab Forme galenique parenterale.
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
AU1442592A (en) * 1991-02-20 1992-09-15 Nova Pharmaceutical Corporation Controlled release microparticulate delivery system for proteins
EP0580778B1 (de) * 1991-04-19 1999-08-11 LDS Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
ES2086022T3 (es) * 1991-07-23 1996-06-16 American Cyanamid Co Composiciones estables para administracion parenteral y su uso.
US5336488A (en) * 1991-08-07 1994-08-09 American Cyanamid Company Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines
IL103275A0 (en) * 1991-10-01 1993-02-21 Lilly Co Eli Injectable extended release formulations and methods
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
WO1994008576A1 (en) * 1992-10-16 1994-04-28 Glaxo Group Limited Taste-masking compositions of ranitidine
US5885486A (en) * 1993-03-05 1999-03-23 Pharmaciaand Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
US5785976A (en) * 1993-03-05 1998-07-28 Pharmacia & Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function
SI0958821T1 (en) * 1996-08-07 2005-02-28 Kyowa Hakko Kogyo Co., Ltd. Fat emulsion containing xanthine derivative
JP2001058955A (ja) * 1999-06-17 2001-03-06 Inst Of Physical & Chemical Res 生理活性ペプチド徐放性製剤
FR2809309B1 (fr) * 2000-05-23 2004-06-11 Mainelab Microspheres a liberation prolongee pour administration injectable
US6967028B2 (en) 2000-07-31 2005-11-22 Mainelab Prolonged release microspheres for injectable administration
AU2002219198B2 (en) * 2000-12-27 2006-06-29 Ares Trading S.A. Lipid microparticles by cryogenic micronization
WO2004069180A2 (en) * 2003-01-31 2004-08-19 Smithkline Beecham Corporation Solid dispersion compositions
CN110036974A (zh) * 2019-03-18 2019-07-23 香格里拉市春树养殖农民专业合作社 一种肉牛的养殖方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS537492B2 (de) * 1973-02-12 1978-03-18
EP0085036A1 (de) * 1982-01-18 1983-08-03 Monsanto Company Verfahren zur Verbesserung der Rindermilchproduktion
IT1190361B (it) * 1985-05-30 1988-02-16 Zambon Spa Composizione farmaceutica in crema per uso dermale ed oftalmico

Also Published As

Publication number Publication date
ATE74009T1 (de) 1992-04-15
ZA875898B (en) 1988-02-12
IL83462A0 (en) 1988-01-31
HUT45887A (en) 1988-09-28
GR3004138T3 (de) 1993-03-31
EP0257368A1 (de) 1988-03-02
FI873465A0 (fi) 1987-08-10
JPS6348223A (ja) 1988-02-29
HU203662B (en) 1991-09-30
DK169123B1 (da) 1994-08-22
AR243079A1 (es) 1993-07-30
NZ221391A (en) 1990-08-28
FI873465A (fi) 1988-02-12
AU7672587A (en) 1988-02-18
AU597708B2 (en) 1990-06-07
DK414987D0 (da) 1987-08-10
IE872129L (en) 1988-02-11
DK414987A (da) 1988-02-12
JP2571790B2 (ja) 1997-01-16
IL83462A (en) 1994-01-25
EP0257368B1 (de) 1992-03-25
CA1296627C (en) 1992-03-03
IE65146B1 (en) 1995-10-04
ES2039219T3 (es) 1993-09-16

Similar Documents

Publication Publication Date Title
DE3777721D1 (de) Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
DE3871751D1 (de) Gelbildende organosiloxanzusammensetzungen und deren verwendung.
DE3786205D1 (de) Titanocene und deren verwendung.
DE3786606T2 (de) Stabilisiertes Benzimidazol-Derivat und Zusammenstellung.
DE19975017I2 (de) Pyridin-Derivate und deren Herstellung.
DE3784199D1 (de) Titanocene und deren verwendung.
DE3784027T3 (de) Absorbierende Produkte und deren Herstellung.
DE3788650T2 (de) Sigma-gehirn-rezeptor-liganden und deren verwendung.
DE3767400D1 (de) Biozide zusammensetzungen und deren verwendung.
DE3580077D1 (de) Bituminoese zusammensetzungen und deren herstellung.
DE3679896D1 (de) Schmiermittelzusammensetzung und verwendung davon.
DE3671446D1 (de) 5-aralkylsubstituierte 2h-benztriazole und stabilisierte zusammensetzungen.
DE267674T1 (de) Zusammensetzungen zur verhinderung von inkrustierungen und deren verwendungen.
DE3688864D1 (de) L-phenylalanindehydrogenase und deren verwendung.
DE3671426D1 (de) Dipropargyloxybenzolverbindungen und deren herstellung.
DE3766441D1 (de) Anilinotriazine und deren verwendung.
DE68907131D1 (de) Antimikrobische zusammensetzung und deren verwendung.
DE3673587D1 (de) Magnetronanode und deren herstellung.
DE3687697D1 (de) Polymerzusammensetzung und deren verwendung.
DE3668173D1 (de) Anthracyclinderivate und deren verwendung.
DE3878349T2 (de) Substituierte acridin-derivate und deren verwendung.
DE3677157D1 (de) Saugfaehige binden und deren herstellung.
DE3868608D1 (de) Organozinn-alkoxycarbonylphenylmercaptide und deren verwendung.
DE3774950D1 (de) Harzartige festkoerperteilchen und deren herstellung.
DE3872764D1 (de) Tinten-zusammensetzungen und deren zubereitung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WYETH HOLDINGS CORP., MADISON, N.J., US

8339 Ceased/non-payment of the annual fee